VKTX - Viking Therapeutics: Another Year In Review
Introduction
It’s closing in on almost 3-years since I first published my initial write-up on Viking Therapeutics (VKTX) back in Oct-2017. I’ve had plenty to say about the company since that time, publishing numerous other articles along the way, but more recently I’ve been quiet about it; and it’s actually almost a year-and-a-half since I last commented with “Year in Review” as a public update. COVID has had a funny way of distorting time and frankly, there just hasn’t been that much to add to the conversation since it entered a